Security key
825693302
Shuttle Pharmaceuticals Holdings, Inc. - Common stock, par value $0.00001 (SHPH)
CUSIP: 825693302
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common stock, par value $0.00001
- Total 13F shares
- 224,874
- Total 13F value
- $87,475
- Share change
- -131,786
- SEC-reported price per share
- $0.39
- Number of holders
- 7
- Value change
- -$66,674
- Number of buys
- 4
- Number of sells
- 3
- Shares outstanding
- 4,075,326
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
7
Top holders
8
SHPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Shuttle Pharmaceuticals Holdings, Inc. SEC filings
Shuttle Pharmaceuticals Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 825693302
Recent filing periods:
Ownership snapshot
Top reported holders of SHPH - Shuttle Pharmaceuticals Holdings, Inc. - Common stock, par value $0.00001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
Mira Jung
Comparable rows
6/15
Latest evidence
31 Dec 2024
13F
13D/G
3/4/5
Lead comparable stake: 10%
9 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 10%.
6 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
10%
UBS Group AG
0.8%
GEODE CAPITAL MANAGEMENT, LLC
0.27%
Tower Research Capital LLC (TRC)
0.17%
Federation Des Caisses Desjardins...
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$262,903
306,057 shares
|
— | 31 Dec 2024 |
| UBS Group AG |
13F
Company
|
0.8%
|
$28,164
32,787 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.27%
|
$9,061
10,867 shares
|
— | 31 Dec 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.17%
|
$5,895
6,863 shares
|
— | 31 Dec 2024 |
| Federation Des Caisses Desjardins du Quebec |
13F
Individual
|
0%
|
$54
63 shares
|
— | 31 Dec 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0%
|
$20
23 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
224,874
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q1 2025 holders
7
Holder diff
6
| Investor | Q3 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend